Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc. (ANVS) has reported earnings 13 times since May 04, 2022. The stock moves an average of ±6.67% the day after reporting, closing higher 61.5% of the time. Its largest post-earnings gain was +20.67% (May 13, 2024) and its largest decline was -21.75% (Apr 03, 2023). The next earnings report is predicted for 2026-08-14 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
13
Avg Abs. Movement
±6.67%
Positive %
61.5%
Negative %
38.5%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | ☽ POST | $2.04 | $2.09 | $2.08 | 32,354 | -1.2% | open_in_new |
| Mar 16, 2026 | ☽ POST | $2.61 | $2.90 | $2.83 | 13,957 | -3.18% | open_in_new |
| Nov 13, 2025 | ☽ POST | $2.43 | $2.43 | $2.29 | 7,810 | +3.49% | open_in_new |
| Aug 12, 2025 | ☽ POST | $2.79 | $2.80 | $2.78 | 3,490 | -3.06% | open_in_new |
| May 13, 2025 | ☽ POST | $1.58 | $1.72 | $1.71 | 19,834 | +0% | open_in_new |
| Mar 21, 2025 | ☽ POST | $1.81 | $1.81 | $1.76 | 4,010 | +3.41% | open_in_new |
| Nov 12, 2024 | ☀ PRE | $7.76 | $7.76 | $7.54 | 1,728 | -0.79% | open_in_new |
| Aug 15, 2024 | ☀ PRE | $8.31 | $9.55 | $8.75 | 5,409 | +12.9% | open_in_new |
| May 13, 2024 | ☽ POST | $6.45 | $7.10 | $6.87 | 5,165 | +20.67% | open_in_new |
| Nov 01, 2023 | ☽ POST | $6.60 | $6.61 | $6.24 | 1,729 | +0.08% | open_in_new |
| Apr 03, 2023 | ☀ PRE | $12.53 | $12.89 | $12.04 | 10,514 | -21.75% | open_in_new |
| Aug 08, 2022 | ☀ PRE | $11.73 | $11.95 | $11.95 | 563 | +5.99% | open_in_new |
| May 04, 2022 | ☀ PRE | $10.80 | $11.45 | $11.45 | 368 | +10.2% | open_in_new |
Earnings Count
13
Total earnings in dataset
Avg Abs. Movement
±6.67%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
6 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260521 | open_in_new SEC.gov |
| 424B5 | 20260520 | open_in_new SEC.gov |
| 8-K | 20260520 | open_in_new SEC.gov |
| 424B5 | 20260519 | open_in_new SEC.gov |
| 10-Q | 20260515 | open_in_new SEC.gov |
| 8-K | 20260515 | open_in_new SEC.gov |
Frequently asked about ANVS earnings
When does Annovis Bio, Inc. report earnings next? expand_more
Annovis Bio, Inc. (ANVS)'s next earnings date is approximate for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ANVS stock move after earnings? expand_more
Over 13 reports, ANVS has moved an average of ±6.67% the session after earnings, closing higher 61.5% of the time.
What was ANVS's biggest post-earnings move? expand_more
ANVS's largest post-earnings gain on record was +20.67% on May 13, 2024, and its largest decline was -21.75% on Apr 03, 2023.
Where can I find Annovis Bio, Inc.'s SEC filings? expand_more
All of Annovis Bio, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right